{"database": "lobbying", "table": "lobbying_activities", "rows": [[2026860, "24dfea5f-8918-464e-910f-2b1d83b8bdab", "Q3", "AVENUE SOLUTIONS", 72111, "JAZZ PHARMACEUTICALS, INC.", 2017, "third_quarter", "PHA", "H.R. 2212/S. 974, Creating and Restoring Equal Access to Equivalent Samples Act of 2017 (CREATES Act of 2017);\nH.R. 2051, FAST Generics Act", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2017-10-17T12:09:22.950000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2026860"], "units": {}, "query_ms": 17.84030208364129, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}